NEW

COVID-19 to impact general surgery procedures in U.S. in 2020, says GlobalData

Most of the hernia procedures to be performed in the U.S. will be delayed due to the COVID-19 crisis, with the exception of a minority of symptomatic cases, but will start to resume towards the end of the second quarter (Q2) of 2020, according to data and analytics...

3NT Medical Announces FDA Clearance for Colibri Endoscopy System

3NT Medical, a privately held corporation dedicated to developing single-use specialized endoscopes for the diagnosis and treatment of ear, nose and throat (ENT) disorders, has announced the FDA 510(k) clearance for the Colibri Micro ENT Scope, the world's first...

ASCA Supports ASC Response to the COVID-19 Pandemic

By Bill Prentice As I write this message, COVID-19 cases in the U.S. are continuing to rise and health care providers, federal and state officials and private citizens across the country are beginning to come to grips with the magnitude of the response needed to...

Challenging Assumptions, Evaluating Routines Can Aid Quality

By Nicholas Schmitz, PMP, LSSBB Across our personal and professional lives, we all fall into many routines; it’s part of how we’re able to perform so many different tasks every day. Have you ever arrived at work (or home), only to realize you don’t even really...

Ambu Launches New Single-Use Cystoscope

Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, introduced a new single-use cystoscope. The Ambu aScope 4 Cysto will give urologists immediate access to a single-use cystoscope that can be used for procedures such as bladder cancer surveillance, stent removal and other common cystoscopy procedures.

Built on more than 10 years of single-use endoscopy experience, the launch of the aScope 4 Cysto enables Ambu to enter a large new market segment. Its new cystoscope will provide urologists a way to better manage their schedules and be more productive without worrying about device deterioration and other issues such as availability, reprocessing and costly repairs.

“This is a game changer,” said Juan Jose Gonzalez, CEO of Ambu S/A, headquartered in Ballerup, Denmark. “Urologists will now have immediate access to a high-quality scope that eliminates reprocessing and repairs. A urologist opens the package and immediately has a new scope offering peak performance with full articulation. They don’t have to wait and worry whether a scope will be available or whether it will work properly.”

The aScope 4 Cysto enables organizations to reduce costs on cleaning supplies, maintenance and repairs (and the associated long-term service contracts). It improves workflow and is portable, which makes it easier for doctors to deal with in-house consult procedures.

“The Cystoscope is a multi-purpose tool used by all urologists; therefore, we are excited to introduce the aScope 4 Cysto which affords urologists excellent imaging, smooth maneuverability, and consistent performance every time,” said Jens Kemp, Ambu Inc.’s vice president of U.S. marketing. “It is a perfect solution for both flexible cystoscopies performed in the outpatient clinic as well as inpatient consults on the ward and ER.”

Ambu, already the world leader in single-use scopes, is ramping up manufacturing to provide a single-use endoscope solution in multiple flexible endoscopy segments, including Pulmonology, ENT, Urology and Gastroenterology. In conjunction with the aScope 4 Cysto and additional endoscopes coming to market, Ambu also recently introduced its aView 2 Advance, a state-of-the-art, high-definition monitor. This mobile platform can be used by pulmonologists, ENTs, urologists, thoracic surgeons, intensive care specialists and other specialists who perform millions of endoscopy procedures each year.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X